Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats

Journal of Hepatology

Volumn 50, Issue 3, 2009, Pages 538-547

  Keshavarzian, Ali ^a   Farhadi, Ashkan ^a   Forsyth, Christopher B ^a   Rangan, Jayanthi ^a   Jakate, Shriram ^a   Shaikh, Maliha ^a   Banan, Ali ^a   Fields, Jeremy Z ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver disease; Alcoholic steatohepatitis; Endotoxemia; Intestinal hyperpermeability; Nitric oxide; Oxidative stress

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; FAT; NITRIC OXIDE;

ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ALCOHOLISM; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTOXEMIA; FEEDING; HEPATITIS; INTESTINE MUCOSA PERMEABILITY; LIPID LIVER LEVEL; LIVER CELL DAMAGE; LIVER INJURY; LONG TERM EXPOSURE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ALCOHOLISM; ANIMALS; CHRONIC DISEASE; ENDOTOXEMIA; ETHANOL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; INFLAMMATION; INTESTINAL MUCOSA; INTESTINES; LIVER; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 59549106331     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.10.028     Document Type: Article

References (49)

1. Maher J.J. Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis 13 (2002) 31-39
2. Burbige E.J., Lewis Jr. D.R., and Halsted C.H. Alcohol and the gastrointestinal tract. Med Clin North Am 68 (1984) 77-89
3. Galambos J.T. Alcoholic hepatitis: its therapy and prognosis. Prog Liver Dis 4 (1972) 567-588
4. Grant B.F., Dufour M.C., and Harford T.C. Epidemiology of alcoholic liver disease. Semin Liver Dis 8 (1988) 12-25
5. Maher J.J. Treatment of alcoholic hepatitis. J Gastroenterol Hepatol 17 (2002) 448-455
6. Nanji A.A., Khettry U., and Sadrzadeh S.M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205 (1994) 243-247
7. Adachi Y., Moore L.E., Bradford B.U., Gao W., and Thurman R.G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108 (1995) 218-224
8. Bhagwandeen B.S., Apte M., Manwarring L., and Dickeson J. Endotoxin induced hepatic necrosis in rats on an alcohol diet. J Pathol 152 (1987) 47-53
9. Bode C., Kugler V., and Bode J.C. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 4 (1987) 8-14
10. Keshavarzian A., Holmes E.W., Patel M., Iber F., Fields J.Z., and Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 94 (1999) 200-207
11. Keshavarzian A., Choudhary S., Holmes E.W., Yong S., Banan A., Jakate S., et al. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 299 (2001) 442-448
12. Davis R.L., Dertien J., and Syapin P.J. Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells. Alcohol Clin Exp Res 26 (2002) 1404-1411
13. Chowdhury P., and Gupta P. Pathophysiology of alcoholic pancreatitis: an overview. World J Gastroenterol 12 (2006) 7421-7427
14. Liedtke A.J., and DeMuth W.E. Effects of alcohol on cardiovascular performance after experimental nonpenetrating chest trauma. Am J Cardiol 35 (1975) 243-250
15. Lumeng L., and Crabb D.W. Alcoholic liver disease. Curr Opin Gastroenterol 16 (2000) 208-218
16. Banan A., Choudhary S., Zhang Y., Fields J.Z., and Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther 291 (1999) 1075-1085
17. Banan A., Fields J.Z., Decker H., Zhang Y., and Keshavarzian A. Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Ther 294 (2000) 997-1008
18. Draper L.R., Gyure L.A., Hall J.G., and Robertson D. Effect of alcohol on the integrity of the intestinal epithelium. Gut 24 (1983) 399-404
19. Farhadi A., Keshavarzian A., Fields J.Z., Sheikh M., and Banan A. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. J Chromatogr B Anal Technol Biomed Life Sci 836 (2006) 63-68
20. Farhadi A., Keshavarzian A., Holmes E.W., Fields J., Zhang L., and Banan A. Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B Anal Technol Biomed Life Sci 784 (2003) 145-154
21. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
22. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957) 497-509
23. Malle E., Furtmuller P.G., Sattler W., and Obinger C. Myeloperoxidase: a target for new drug development?. Br J Pharmacol 152 (2007) 838-854
24. Banan A., Zhang L.J., Shaikh M., Fields J.Z., Farhadi A., and Keshavarzian A. Novel effect of NF-kappaB activation: carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium. Am J Physiol Cell Physiol 287 (2004) C1139-C1151
25. Keshavarzian A., Banan A., Farhadi A., Komanduri S., Mutlu E., Zhang Y., et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52 (2003) 720-728
26. Bigatello L.M., Broitman S.A., Fattori L., Di Paoli M., Pontello M., Bevilacqua G., et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 82 (1987) 11-15
27. Criado-Jimenez M., Rivas-Cabanero L., Martin-Oterino J.A., Lopez-Novoa J.M., and Sanchez-Rodriguez A. Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis. J Mol Med 73 (1995) 31-33
28. Hunt N.C., and Goldin R.D. Nitric oxide production by monocytes in alcoholic liver disease. J Hepatol 14 (1992) 146-150
29. McClain C.J., and Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9 (1989) 349-351
30. Nanji A.A., Khettry U., Sadrzadeh S.M., and Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 142 (1993) 367-373
31. Hill D SS, McClain C, Diehl A, Tsukamoto H. Cytokines and liver disease. Marcel Dekker Ltd.; 1997. p. 401-425.
32. Hall P.D. Pathological spectrum of alcoholic liver disease. Alcohol Alcohol Suppl 2 (1994) 303-313
33. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 27 (1992) 721-726
34. Menzies I.S., Laker M.F., Pounder R., Bull J., Heyer S., Wheeler P.G., et al. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 2 (1979) 1107-1109
35. Hansen J., Cherwitz D.L., and Allen J.I. The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology 20 (1994) 461-474
36. Rubin E., Rybak B.J., Lindenbaum J., Gerson C.D., Walker G., and Lieber C.S. Ultrastructural changes in the small intestine induced by ethanol. Gastroenterology 63 (1972) 801-814
37. Lindenbaum J., and Lieber C.S. Effects of chronic ethanol administration on intestinal absorption in man in the absence of nutritional deficiency. Ann NY Acad Sci 252 (1975) 228-234
38. Keshavarzian A., Iber F.L., Dangleis M.D., and Cornish R. Intestinal-transit and lactose intolerance in chronic alcoholics. Am J Clin Nutr 44 (1986) 70-76
39. Bode J.C., Knuppel H., Schwerk W., Lorenz-Meyer H., and Durr H.K. Quantitative histomorphometric study of the jejunal mucosa in chronic alcoholics. Digestion 23 (1982) 265-270
40. Ishii H. Oxidative stress in alcoholic liver injury. Alcohol Clin Exp Res 20 (1996) 162A-167A
41. Kurose I., Higuchi H., Kato S., Miura S., and Ishii H. Ethanol-induced oxidative stress in the liver. Alcohol Clin Exp Res 20 (1996) 77A-85A
42. Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 23 (2007) 283-291
43. Banan A., Choudhary S., Zhang Y., Fields J.Z., and Keshavarzian A. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med 28 (2000) 727-738
44. Banan A., Fields J.Z., Zhang Y., and Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 280 (2001) G1234-G1246
45. Rao R.K., Baker R.D., Baker S.S., Gupta A., and Holycross M. Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Am J Physiol 273 (1997) G812-G823
46. Rao R.K., Basuroy S., Rao V.U., Karnaky Jr. K.J., and Gupta A. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 368 (2002) 471-481
47. Moncada S., and Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev Mol Cell Biol 3 (2002) 214-220
48. Antunes F., Boveris A., and Cadenas E. On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. Proc Natl Acad Sci USA 101 (2004) 16774-16779
49. Banan A., Keshavarzian A., Zhang L., Shaikh M., Forsyth C.B., Tang Y., et al. NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol 41 (2007) 447-460